2nd Quarter - Report
THE PAUL LAXALT GROUP for THE ROGOSIN INSTITUTE
Client
Income
$20,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Legislation and regulations relating to Medicare policies that impact care provided to patients with kidney disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TOM LORANGER | — |
Medical/Disease Research/Clinical Labs MED
Monitor issues concerning improvements in medical research and treatment of kidney disease. Dialysis PATIENTS Demonstration Act of 2017 - HR 4143 and S 2065 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 - HR 2644 and S 1980
| Lobbyist | Covered position, as disclosed |
|---|---|
| TOM LORANGER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.